Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases

Neurology Journal

Fecha de publicación: 8 December 2017
DOI: https://doi.org/10.1212/WNL.0000000000004803
Autores: Divyanshu Dubey, Vanda A. Lennon, Avi Gadoth, Sean J. Pittock, Eoin P. Flanagan, John E. Schmeling, Andrew McKeon and Christopher J. Klein

Background: To establish the phenotype and clinical outcomes of collapsin response-mediator protein-5 (CRMP5) autoimmune neuropathy in comparison with anti-neuronal nuclear antibody type 1 (ANNA1)–immunoglobulin G (IgG) neuropathy.
 

SEGUIR LEYENDO

Enviar comentario